Antibody-Drug Conjugates in Ovarian Cancer: Promises and Challenges
Ovarian cancer (OC) remains one of the most lethal gynecological malignancies globally, often detected at advanced stages which contribute to its high mortality rate. Recurrent and drug-resistant cases further complicate the therapeutic landscape, underscoring the urgent need for innovative treatmen...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2023-10-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/HBT.OH.2023.17.119 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|